BALTRUŠKEVIČIENĖ, Edita; MICKYS, Ugnius; ŽVIRBLIS, Tadas; STULPINAS, Rokas; PIPIRIENĖ ŽELVIENĖ, Teresė; ALEKNAVIČIUS, Eduardas. Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience. Acta medica Lituanica, [S. l.], v. 23, n. 1, p. 24–34, 2016. DOI: 10.6001/actamedica.v23i1.3267. Disponível em: https://www.journals.vu.lt/AML/article/view/21456.. Acesso em: 7 may. 2024.